Anika Therapeutics Inc ANIK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANIK is a good fit for your portfolio.
News
-
Anika Announces CFO Transition
-
Anika Reports First Quarter 2024 Financial Results
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
-
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
Trading Information
- Previous Close Price
- $25.26
- Day Range
- $25.32–26.36
- 52-Week Range
- $16.54–28.67
- Bid/Ask
- $10.26 / $40.75
- Market Cap
- $380.05 Mil
- Volume/Avg
- 85,864 / 82,138
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.22
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.32%
Company Profile
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 357
- Website
- https://www.anika.com
Comparables
Valuation
Metric
|
ANIK
|
NARI
|
ATEC
|
---|---|---|---|
Price/Earnings (Normalized) | — | 456.17 | — |
Price/Book Value | 1.74 | 5.51 | 42.72 |
Price/Sales | 2.22 | 4.69 | 2.91 |
Price/Cash Flow | 35.82 | 97.99 | — |
Price/Earnings
ANIK
NARI
ATEC
Financial Strength
Metric
|
ANIK
|
NARI
|
ATEC
|
---|---|---|---|
Quick Ratio | 3.50 | 2.09 | 1.37 |
Current Ratio | 5.26 | 2.71 | 2.39 |
Interest Coverage | — | −98.60 | −9.60 |
Quick Ratio
ANIK
NARI
ATEC
Profitability
Metric
|
ANIK
|
NARI
|
ATEC
|
---|---|---|---|
Return on Assets (Normalized) | 0.92% | 2.99% | −9.36% |
Return on Equity (Normalized) | 1.13% | 3.92% | — |
Return on Invested Capital (Normalized) | 0.17% | 1.60% | −9.08% |
Return on Assets
ANIK
NARI
ATEC
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Nnfplwyw | Cwhp | $134.9 Bil | |
BDX
| Becton Dickinson & Co | Vdxhslq | Zvzct | $67.5 Bil | |
ALC
| Alcon Inc | Szvgklyhw | Dmlkg | $39.6 Bil | |
RMD
| ResMed Inc | Fjlcgwctw | Ktswzj | $31.3 Bil | |
CLPBY
| Coloplast A/S ADR | Spsnmpxtc | Vyhq | $27.4 Bil | |
WST
| West Pharmaceutical Services Inc | Hdcdryyt | Jytm | $26.7 Bil | |
COO
| The Cooper Companies Inc | Scszkjrv | Pzlvr | $18.8 Bil | |
BAX
| Baxter International Inc | Jqtvxrg | Hhvkdj | $18.3 Bil | |
HOLX
| Hologic Inc | Tjspyxgtj | Jwjbl | $17.7 Bil | |
ATR
| AptarGroup Inc | Ynyrswfdb | Bxgfhb | $9.8 Bil |